Obesity Clinical Trial
Official title:
Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women.
Verified date | February 2018 |
Source | University of Hohenheim |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to investigate how a high-fructose diet, either by high fructose intake from complex, natural foods or by fortifying the diet with corn syrup, affects the metabolism. Furthermore, it will be investigate if there are differences between obese and normal weight participants.
Status | Completed |
Enrollment | 12 |
Est. completion date | October 15, 2009 |
Est. primary completion date | October 15, 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 20 Years to 30 Years |
Eligibility |
Inclusion Criteria: - Healthy adults, aged between 20 and 30 years - normal weighted (BMI = 25 kg/m2) and obese (BMI 35-50 kg/m2) - written informed consent At initial medical examination an anamnesis, physical examination, blood sample collection (10 ml) was performed to check for eligibility. Furthermore, a hydrogen breath test was performed to detect potential fructose intolerance Exclusion Criteria: - smoking, - fructose intolerance/ -malabsorption, - pregnancy - chronic gastrointestinal diseases (e.g. chronic inflammatory bowel disease, irritable bowel syndrome, celiac disease etc.), - operation on the gastrointestinal tract (exclusively appendectomy) - anemia, - hepatic or renal disease - diabetes mellitus - consuming illnesses (e.g. cancer, acquired immunodeficiency syndrome (AIDS)) - drug intake affecting lipid or glucose metabolism (cholesterol- or glucose reducing or antihypertensive drugs, steroids, L-Thyroxin, antidepressants, weight reducing drugs). |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Hohenheim |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | metabolite concentration | The primary endpoint is the change of metabolite concentration after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | fatty liver index | Change in fatty liver index after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | Non-alcoholic fatty liver disease (NAFLD) | Change in the classification of non-alcoholic fatty liver disease (NAFLD) based on ultrasound after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | Body weight | Change from baseline in body weight after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | Blood pressure (systolic and diastolic) | Change in blood pressure (systolic and diastolic) after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | GGT | Change in GGT after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | GOT | Change in GOT after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | GPT | Change in GPT after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | AP | Change in AP after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | Triglycerides | Change in triglycerides after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | HDL | Change in HDL after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | LDL | Change in LDL after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | Fasting glucose | Change in fasting glucose after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | BSR | Change in BSR after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | Kreatinine | Change in Kreatinine after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | Uric acid | Change in uric acid after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | Urea | Change in urea after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | Cholesterol | Change in cholesterol after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | Ghrelin | Change in ghrelin after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. | |
Secondary | Leptin | Change in leptin after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet. | Participants will be followed for the time of four weeks. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |